President Trump’s pick to lead the country’s drug regulatory agency could usher in major reforms.
The FDA wants to regulate animals altered using the gene-editing technique CRISPR.
A brain-computer interface records “yes” and “no” answers in patients who lack any voluntary muscle movement.
Effort to grow organs stirs debate over ethics of human-animal chimeras.
Researchers claim that additive manufacturing can now produce functional skin, and the first internal organs may be ready within six years.
In a medical first, the children were treated with genetically engineered T-cells from another person.
A startup uses algorithms that understand the anatomy of cells to discover new uses for existing drugs.
More than half of pediatric cancer patients have genetic faults that could affect their diagnosis or be targeted by drugs.
The regulator has suggested that it treat every edit of an animal’s genome like a new drug, but some scientists think it could slow progress.
Researchers enlist smartphones and machine learning to find vocal patterns that might signal post-traumatic stress disorder or even heart disease.